Redeye gives a short comment on today’s May ARR update from Hoylu.
Redeye thinks that the new evidence from the patent founder was strong and improves Neonode’s chance...
Redeye has a positive view of the preliminary results from the ongoing iHand study presented at the ...
Redeye is encouraged by the news that ISAB´s collaboration with RISE has been successful on the firs...
Strangvac börjar sin resa Intervacc går nu in i en ny fas då deras första vaccin Strangvac, mot den ...
Säkerhetsmedvetenheten har accentuerats Företags inköp av säkerhetstjänster ökade med 6% per år 2016...
SRV embarked on the last phases of its balance sheet strengthening program.
Omsättningstillväxten var blygsam och kostnaderna kom in högre än väntat, men nya avtal bäddar för s...
LL Lucky Games AB (”LL Lucky Games" eller "Bolaget”) fortsätter växa, lanserar nya spel, siktar mot ...
Under det första kvartalet 2022 rapporterade DanCann intäkter och lönsamhet som var något lägre än v...
Key message: Pricer sees strong growth prospects New ‘25 sales target: SEK 4.
We attended the American Society of Clinical Oncology (ASCO) conference in Chicago on 3-7 June, at w...
Redeye updates its view on Embracer post the company’s Q4-results which was in line with our expecta...
Redeye notes that the magnitude of impact from COGS price inflation is significant.
Redeye provides its thoughts on the three communicated partnerships in May (with CYE, Cinia and Keto...
Nordec is one of the leading providers of steel frame structures and envelope solutions for construc...
Redeye initiates coverage of CombinedX, a decentralized group of specialized IT consulting firms.
Abliva tar in kapital för att starta sin studie med KL1333.
Cantargia presented positive interim data at the American Society of Clinical Oncology (ASCO) 2022 t...
Tethys Oil sänker produktionsguidningen något för 2022 och har lämnat lovande resultat från borrning...
